EFEKTIVITAS PENERAPAN INTAGRATED CLINICAL PATHWAY PADA PENYAKIT PARU: LITERATURE REVIEW
Abstract
Globally, lung disease is one of the contributors to the increase in inpatients and the use of health facilities in hospitals. This literature review aims to identify the effectiveness of implementing integrated clinical pathways in lung disease. Methods: The design of this research is a literature review. Search articles using Pubmed, Ebsco, Cochrane Library, and Proquest databases. Structured research questions using the PICO method, and search keywords based on the database in MeSH Term. The inclusion criteria are focused on the application of integrated clinical pathways, applied to health care facilities, applied to lung disease, published in the last 10 years, and in English. There were 3582 articles found, and only 8 articles were included which matched the research question. Results: There were 8 articles included in this study. From the results of a critical assessment of the included articles, the application of ICP in lung disease can reduce patient length of stay, reduce patient care costs, reduce the number of patient readmissions, and reduce drug use in hospitals. Conclusion: The application of ICP in lung disease improves patient outcomes, therefore ICP can be recommended to health care agencies, especially health management.
Keywords
Full Text:
PDFReferences
Abela, L., Pace, A., & Buttigieg, S. C. (2019). What affects length of hospital stay? A case study from Malta. Journal of Health Organization and Management, 33(6), 714–736.
Ambroggio, L., Thomson, J., Kurowski, E. M., Courter, J., Statile, A., Graham, C., … White, C. M. (2013). Quality improvement methods increase appropriate antibiotic prescribing for childhood pneumonia. Pediatrics, 131(5).
Becker, A. B., & Abrams, E. M. (2017). Asthma guidelines: The global initiative for asthma in relation to national guidelines. Current Opinion in Allergy and Clinical Immunology, 17(2), 99–103.
Bryan, M. A., Desai, A. D., Wilson, L., Wright, D. R., & Mangione-Smith, R. (2017). Association of bronchiolitis clinical pathway adherence with length of stay and costs. Pediatrics, 139(3).
Carratalà, J., Garcia-Vidal, C., Ortega, L., Fernández-Sabé, N., Clemente, M., Albero, G., … Gudiol, F. (2012). Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: A randomized controlled trial. Archives of Internal Medicine, 172(12), 922–928.
Chen, K. H., Chen, C., Liu, H. E., Tzeng, P. C., & Glasziou, P. P. (2014). Effectiveness of paediatric asthma clinical pathways: A narrative systematic review. Journal of Asthma, 51(5), 480–492.
Cho, S. J., & Stout-Delgado, H. W. (2020). Aging and Lung Disease. Annual Review of Physiology, 82, 433–459.
Donà, D., Zingarella, S., Gastaldi, A., Lundin, R., Perilongo, G., Frigo, A. C., … Giaquinto, C. (2018). Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia. PLoS ONE, 13(2), 1–15.
Duman, D., Aksoy, E., Agca, M. C., Kocak, N. D., Ozmen, I., Akturk, U. A., … Karakurt, Z. (2015). The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. International Journal of COPD, 10(1), 2469–2478.
Eriksen, M. B., & Frandsen, T. F. (2018). The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. Journal of the Medical Library Association, 106(4), 10–11.
Guarnaccia, S., Pecorelli, G., Bianchi, M., Cartabia, M., Casadei, G., Pluda, A., … Bonati, M. (2017). IOEASMA: An integrated clinical and educational pathway for managing asthma in children and adolescents. Italian Journal of Pediatrics, 43(1), 1–7.
Gurria, J. P., Simpson, B., Tuncel-Kara, S., Bates, C., McKenna, E., Rogers, T., … Brown, R. L. (2020). Standardization of clinical care pathway leads to sustained decreased length of stay following Nuss pectus repair: A multidisciplinary quality improvement initiative. Journal of Pediatric Surgery, 55(12), 2690–2698.
Hasegawa, K., Tsugawa, Y., Brown, D. F. M., Mansbach, J. M., & Camargo, C. A. (2013). Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics, 132(1), 28–36.
Jenkins, T. C., Irwin, A., Coombs, L., Dealleaume, L., Ross, S. E., Rozwadowski, J., … Price, C. S. (2013). Effects of clinical pathways for common outpatient infections on antibiotic prescribing. American Journal of Medicine, 126(4), 327–335.e12.
Khosravizadeh, O., Vatankhah, S., Jahanpour, M., Yousefzadeh, N., Shahsavari, S., & Yari, S. (2020). Predicting inpatient length of stay in Iranian Hospital: Conceptualization and validation. Asian Pacific Journal of Cancer Prevention, 21(8), 2439–2446.
Leyenaar, J. K., Lagu, T., Shieh, M. S., Pekow, P. S., & Lindenauer, P. K. (2014). Variation in resource utilization for the management of uncomplicated community-acquired pneumonia across community and children’s hospitals. Journal of Pediatrics, 165(3), 585–591.
Pound, C. M., Gelt, V., Akiki, S., Eady, K., Moreau, K., Momoli, F., … Kovesi, T. (2017). Nurse-Driven Clinical Pathway for Inpatient Asthma: A Randomized Controlled Trial. Hospital Pediatrics, 7(4), 204–213.
Ralston, S., Garber, M., Narang, S., Shen, M., Pate, B., Pope, J., … Ryan, M. (2013). Decreasing unnecessary utilization in acute bronchiolitis care: Results from the value in inpatient pediatrics network. Journal of Hospital Medicine, 8(1), 25–30.
Reddel, H. K., Bateman, E. D., Becker, A., Boulet, L. P., Cruz, A. A., Drazen, J. M., … FitzGerald, J. M. (2015). A summary of the new GINA strategy: A roadmap to asthma control. European Respiratory Journal, 46(3), 622–639.
Rotter, T., Kinsman, L., James, E., Machotta, A., Gothe, H., Willis, J., … Kugler, J. (2011). Clinical pathways: Effects on professional practice, patient outcomes, length of stay and hospital costs. International Journal of Evidence-Based Healthcare, 9(2), 191–192.
Sharif, S. M., Rahman, J. A., Latif, H. A., Awang, R. A., Daud, M., Abdullah, A. F., … Zainudin, N. M. (2019). Paediatric asthma clinical pathway: Impact on cost and quality of care. Medical Journal of Malaysia, 74(2), 138–144.
Sylvester, A. M., & George, M. (2014). Effect of a Clinical Pathway on Length of Stay and Cost of Pediatric Inpatient Asthma Admissions: An Integrative Review. Clinical Nursing Research, 23(4), 384–401.
Vanhaecht, K., Lodewijckx, C., Sermeus, W., Decramer, M., Deneckere, S., Leigheb, F., … Panella, M. (2016). Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: A cluster randomized trial. International Journal of COPD, 11(1), 2897–2908.
Vanhaecht, K., Sermeus, W., Peers, J., Euwema, M., Boonen, S., Cittaro, W., … Mendez, R. V. (2010). The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: Rationale and design of a cluster randomized controlled trial. Trials, 11, 1–7.
von Eiff, W. (2015). International benchmarking and best practice management: in search of health care and hospital excellence. International Best Practices in Health Care Management, 17, 223–252.
Walker, C., Danby, S., & Turner, S. (2012). Impact of a bronchiolitis clinical care pathway on treatment and hospital stay. European Journal of Pediatrics, 171(5), 827–832.
White, S. M., & Hill, A. (2014). A heart failure initiative to reduce the length of stay and readmission rates. Professional Case Management, 19(6), 276–284.
Wong, G. W. K., Kwon, N., Hong, J. G., Hsu, J. Y., & Gunasekera, K. D. (2013). Pediatric asthma control in Asia: Phase 2 of the Asthma Insights and Reality in Asia-Pacific (AIRIAP 2) survey. Allergy: European Journal of Allergy and Clinical Immunology, 68(4), 524–530.
Zorc, J. J., & Hall, C. B. (2010). Bronchiolitis: Recent evidence on diagnosis and management. Pediatrics, 125(2), 342–349.
Refbacks
- There are currently no refbacks.
